Meier Hsu

5.3k total citations
131 papers, 3.5k citations indexed

About

Meier Hsu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Meier Hsu has authored 131 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pulmonary and Respiratory Medicine, 44 papers in Oncology and 38 papers in Surgery. Recurrent topics in Meier Hsu's work include Esophageal Cancer Research and Treatment (19 papers), Esophageal and GI Pathology (16 papers) and Gastric Cancer Management and Outcomes (15 papers). Meier Hsu is often cited by papers focused on Esophageal Cancer Research and Treatment (19 papers), Esophageal and GI Pathology (16 papers) and Gastric Cancer Management and Outcomes (15 papers). Meier Hsu collaborates with scholars based in United States, China and Australia. Meier Hsu's co-authors include Mark G. Kris, Michael T. Longaker, Gyu S. Chin, Ziv M. Peled, Marc Ladanyi, Jenifer L. Marks, Vincent A. Miller, Daniel G. Rosenbaum, Khédoudja Nafa and Elyn Riedel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Meier Hsu

127 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meier Hsu United States 31 1.4k 1.3k 871 749 464 131 3.5k
Daniela Campani Italy 38 660 0.5× 2.0k 1.5× 1.4k 1.5× 1.3k 1.7× 427 0.9× 176 4.8k
Markus Steinbauer Germany 24 718 0.5× 804 0.6× 1.1k 1.3× 967 1.3× 214 0.5× 86 3.3k
Carla Rabitti Italy 33 556 0.4× 984 0.7× 922 1.1× 1.5k 2.0× 317 0.7× 109 4.0k
Ayumi Yoshizaki Japan 34 787 0.6× 919 0.7× 962 1.1× 339 0.5× 1.9k 4.1× 192 4.8k
Hee Chul Park South Korea 33 1.2k 0.8× 1.6k 1.2× 416 0.5× 1.3k 1.8× 311 0.7× 201 4.1k
Seena C. Aisner United States 30 1.5k 1.1× 1.8k 1.4× 1.2k 1.3× 458 0.6× 290 0.6× 100 4.4k
Toru Nakanishi Japan 34 695 0.5× 682 0.5× 1.1k 1.2× 930 1.2× 585 1.3× 148 4.3k
Niki J. Agnantis Greece 32 543 0.4× 1.4k 1.0× 1.5k 1.8× 758 1.0× 598 1.3× 182 4.1k
Nikoletta Nagy Belgium 30 263 0.2× 717 0.5× 1.3k 1.5× 471 0.6× 302 0.7× 145 3.5k
Adam C. Berger United States 33 1.1k 0.8× 2.7k 2.1× 1.7k 2.0× 1.4k 1.9× 235 0.5× 137 4.8k

Countries citing papers authored by Meier Hsu

Since Specialization
Citations

This map shows the geographic impact of Meier Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meier Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meier Hsu more than expected).

Fields of papers citing papers by Meier Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meier Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meier Hsu. The network helps show where Meier Hsu may publish in the future.

Co-authorship network of co-authors of Meier Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Meier Hsu. A scholar is included among the top collaborators of Meier Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meier Hsu. Meier Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deipolyi, Amy R., Christopher Johnson, Christopher C. Riedl, et al.. (2022). Prospective Evaluation of Immune Activation Associated with Response to Radioembolization Assessed with PET/CT in Women with Breast Cancer Liver Metastasis. Radiology. 306(1). 279–287. 13 indexed citations
2.
Chudgar, Neel P., Yan Shi, Meier Hsu, et al.. (2021). The American College of Surgeons Surgical Risk Calculator performs well for pulmonary resection: A validation study. Journal of Thoracic and Cardiovascular Surgery. 163(4). 1509–1516.e1. 6 indexed citations
3.
Ridouani, Fourat, Mohamed Mohamed Soliman, Ryan W. England, et al.. (2021). Relationship of radiation dose to efficacy of radioembolization of liver metastasis from breast cancer. European Journal of Radiology. 136. 109539–109539. 10 indexed citations
5.
Chudgar, Neel P., Yan Shi, Meier Hsu, et al.. (2020). Performance Comparison Between SURPAS and ACS NSQIP Surgical Risk Calculator in Pulmonary Resection. The Annals of Thoracic Surgery. 111(5). 1643–1651. 10 indexed citations
6.
Barbetta, Arianna, Meier Hsu, Kay See Tan, et al.. (2018). Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma. Journal of Thoracic and Cardiovascular Surgery. 155(6). 2710–2721.e3. 38 indexed citations
7.
Nobel, Tamar, Arianna Barbetta, Meier Hsu, et al.. (2018). Outcomes of Radiation-Associated Esophageal Squamous Cell Carcinoma: The MSKCC Experience. Journal of Gastrointestinal Surgery. 23(1). 11–22. 8 indexed citations
8.
Barbetta, Arianna, Smita Sihag, Tamar Nobel, et al.. (2018). Patterns and risk of recurrence in patients with esophageal cancer with a pathologic complete response after chemoradiotherapy followed by surgery. Journal of Thoracic and Cardiovascular Surgery. 157(3). 1249–1259.e5. 47 indexed citations
9.
Barbetta, Arianna, Tamar Nobel, Smita Sihag, et al.. (2018). Neutrophil to Lymphocyte Ratio as Predictor of Treatment Response in Esophageal Squamous Cell Cancer. The Annals of Thoracic Surgery. 106(3). 864–871. 28 indexed citations
11.
Goldberg, Aaron D., Troy Z. Horvat, Meier Hsu, et al.. (2017). Venetoclax Combined with Either a Hypomethylating Agent or Low-Dose Cytarabine Shows Activity in Relapsed and Refractory Myeloid Malignancies. Blood. 130. 1353–1353. 18 indexed citations
14.
Li, Bob T., Dara S. Ross, Dara L. Aisner, et al.. (2015). HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers. Journal of Thoracic Oncology. 11(3). 414–419. 212 indexed citations
15.
Karakousis, Giorgos C., Neeta Pandit‐Taskar, Meier Hsu, et al.. (2012). Prognostic significance of drainage to pelvic nodes at sentinel lymph node mapping in patients with extremity melanoma. Melanoma Research. 23(1). 40–46. 7 indexed citations
16.
Chan, Andrew T., Meier Hsu, Ann G. Zauber, Ernest T. Hawk, & Monica M. Bertagnolli. (2011). The Influence of UGT1A6 Variants and Aspirin Use in a Randomized Trial of Celecoxib for Prevention of Colorectal Adenoma. Cancer Prevention Research. 5(1). 61–72. 13 indexed citations
17.
Smyth, Elizabeth, Meier Hsu, K. Panageas, & Paul B. Chapman. (2011). Histology and outcomes of newly detected lung lesions in melanoma patients. Annals of Oncology. 23(3). 577–582. 14 indexed citations
18.
Thornton, Raymond H., Robert J. Ulrich, Meier Hsu, et al.. (2011). Outcomes of Patients Undergoing Percutaneous Biliary Drainage to Reduce Bilirubin for Administration of Chemotherapy. Journal of Vascular and Interventional Radiology. 23(1). 89–95. 32 indexed citations
19.
Chan, Andrew T., Ann G. Zauber, Meier Hsu, et al.. (2009). Cytochrome P450 2C9 Variants Influence Response to Celecoxib for Prevention of Colorectal Adenoma. Gastroenterology. 136(7). 2127–2136.e1. 41 indexed citations
20.
Atadja, Peter, et al.. (2004). Molecular and Cellular Basis for the Anti‐Proliferative Effects of the HDAC Inhibitor LAQ824. Novartis Foundation symposium. 259. 249–268. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026